Zinc Inhibition Helps Lab-Grown Pancreatic Cells Survive Transplantation

This breakthrough research addresses a major obstacle in diabetes treatment using lab-grown pancreatic cells. Scientists have struggled with stem cell-derived islet organoids (SC-islets) that fail after transplantation due to oxygen deprivation and poor blood vessel formation.

The study revealed that excessive zinc accumulation in these engineered pancreatic beta cells triggers harmful oxidative stress, which shuts down a key cellular energy sensor called AMPK. This leads to poor cell function and reduced production of VEGFA, a protein essential for blood vessel growth.

By chemically blocking zinc transport into the cells, researchers activated AMPK, improved cell maturation, and enhanced resistance to low-oxygen conditions. Crucially, this treatment boosted VEGFA production through a novel pathway independent of the usual hypoxia response, promoting better integration with blood vessels.

In diabetic animal models, the zinc-blocked islets showed dramatically improved survival rates, faster blood vessel formation around transplanted cells, and better blood sugar control compared to untreated cells.

This pre-adaptation strategy could transform regenerative medicine approaches for diabetes. Rather than waiting for transplanted cells to adapt to their new environment, scientists can now prepare them beforehand to handle the stressful conditions they'll encounter. The findings may also apply to other organ transplantation scenarios where oxygen deprivation threatens graft survival.